Tumor immunogenicity dictates reliance on TCF1 in CD8+T cells for response to immunotherapy

被引:35
作者
Escobar, Giulia [1 ,2 ]
Tooley, Katherine [1 ,2 ,3 ]
Oliveras, Joan Pages [1 ,2 ]
Huang, Linglin [1 ,2 ]
Cheng, Hanning [1 ,2 ]
Bookstaver, Michelle L. [1 ,2 ]
Edwards, Camilla [5 ]
Froimchuk, Eugene [5 ]
Xue, Chang [1 ,2 ]
Mangani, Davide [1 ,2 ]
Krishnan, Rajesh K. [1 ,2 ]
Hazel, Natanael [1 ,2 ]
Rutigliani, Carola [1 ,2 ]
Jewell, Christopher M. [5 ,6 ]
Biasco, Luca [4 ]
Anderson, Ana C. [1 ,2 ]
机构
[1] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Med Sch, Div Med Sci, Boston, MA USA
[4] UCL, Great Ormond St Inst Child Hlth, London, England
[5] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA
[6] VA Maryland Hlth Care Syst, US Dept Vet Affairs, Baltimore, MD 21201 USA
关键词
CD8(+) T-CELLS; IMMUNITY;
D O I
10.1016/j.ccell.2023.08.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Stem-like CD8+ T cells are regulated by T cell factor 1 (TCF1) and are considered requisite for immune checkpoint blockade (ICB) response. However, recent findings indicate that reliance on TCF1+CD8+ T cells for ICB efficacy may differ across tumor contexts. We find that TCF1 is essential for optimal priming of tumor antigen specific CD8+ T cells and ICB response in poorly immunogenic tumors that accumulate TOX+ dysfunctional T cells, but is dispensable for T cell priming and therapy response in highly immunogenic tumors that efficiently expand transitory effectors. Importantly, improving T cell priming by vaccination or by enhancing antigen presentation on tumors rescues the defective responses of TCF1-deficient CD8+ T cells upon ICB in poorly immunogenic tumors. Our study highlights TCF1's role during the early stages of anti-tumor CD8+ T cell responses with important implications for guiding optimal therapeutic interventions in cancers with low TCF1+CD8+ T cells and low-neo-antigen expression.
引用
收藏
页码:1662 / +
页数:26
相关论文
共 57 条
[41]   Intratumoral Tcf1+PD-1+CD8+ T Cells with Stem-like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy [J].
Siddiqui, Imran ;
Schaeuble, Karin ;
Chennupati, Vijaykumar ;
Marraco, Silvia A. Fuertes ;
Calderon-Copete, Sandra ;
Ferreira, Daniela Pais ;
Carmona, Santiago J. ;
Scarpellino, Leonardo ;
Gfeller, David ;
Pradervand, Sylvain ;
Luther, Sanjiv A. ;
Speiser, Daniel E. ;
Held, Werner .
IMMUNITY, 2019, 50 (01) :195-+
[42]   A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells [J].
Singer, Meromit ;
Wang, Chao ;
Cong, Le ;
Marjanovic, Nemanja D. ;
Kowalczyk, Monika S. ;
Zhang, Huiyuan ;
Nyman, Jackson ;
Sakuishi, Kaori ;
Kurtulus, Sema ;
Gennert, David ;
Xia, Junrong ;
Kwon, John Y. H. ;
Nevin, James ;
Herbst, Rebecca H. ;
Yanai, Itai ;
Rozenblatt-Rosen, Orit ;
Kuchroo, Vijay K. ;
Regev, Aviv ;
Anderson, Ana C. .
CELL, 2016, 166 (06) :1500-+
[43]   Systemic Immunity Is Required for Effective Cancer Immunotherapy [J].
Spitzer, Matthew H. ;
Carmi, Yaron ;
Reticker-Flynn, Nathan E. ;
Kwek, Serena S. ;
Madhireddy, Deepthi ;
Martins, Maria M. ;
Gherardini, Pier Federico ;
Prestwood, Tyler R. ;
Chabon, Jonathan ;
Bendall, Sean C. ;
Fong, Lawrence ;
Nolan, Garry P. ;
Engleman, Edgar G. .
CELL, 2017, 168 (03) :487-+
[44]   Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment [J].
Spranger, Stefani ;
Koblish, Holly K. ;
Horton, Brendan ;
Scherle, Peggy A. ;
Newton, Robert ;
Gajewski, Thomas F. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2014, 2
[45]   A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade [J].
Thommen, Daniela S. ;
Koelzer, Viktor H. ;
Herzig, Petra ;
Roller, Andreas ;
Trefny, Marcel ;
Dimeloe, Sarah ;
Kiialainen, Anna ;
Hanhart, Jonathan ;
Schill, Catherine ;
Hess, Christoph ;
Prince, Spasenija Savic ;
Wiese, Mark ;
Lardinois, Didier ;
Ho, Ping-Chih ;
Klein, Christian ;
Karanikas, Vaios ;
Mertz, Kirsten D. ;
Schumacher, Ton N. ;
Zippelius, Alfred .
NATURE MEDICINE, 2018, 24 (07) :994-+
[46]  
Tosti A., 1987, G. Ital. Dermatol. Venereol., V122, P1579
[47]   Altering Antigen Charge to Control Self-Assembly and Processing of Immune Signals During Cancer Vaccination [J].
Tsai, Shannon J. ;
Amerman, Allie ;
Jewell, Christopher M. .
FRONTIERS IN IMMUNOLOGY, 2021, 11
[48]   MYB orchestrates T cell exhaustion and response to checkpoint inhibition [J].
Tsui, Carlson ;
Kretschmer, Lorenz ;
Rapelius, Svenja ;
Gabriel, Sarah S. ;
Chisanga, David ;
Knoepper, Konrad ;
Utzschneider, Daniel T. ;
Nuessing, Simone ;
Liao, Yang ;
Mason, Teisha ;
Torres, Santiago Valle ;
Wilcox, Stephen A. ;
Kanev, Krystian ;
Jarosch, Sebastian ;
Leube, Justin ;
Nutt, Stephen L. ;
Zehn, Dietmar ;
Parish, Ian A. ;
Kastenmueller, Wolfgang ;
Shi, Wei ;
Buchholz, Veit R. ;
Kallies, Axel .
NATURE, 2022, 609 (7926) :354-+
[49]   Antigen-driven EGR2 expression is required for exhausted CD8+ T cell stability and maintenance [J].
Wagle, Mayura, V ;
Vervoort, Stephin J. ;
Kelly, Madison J. ;
Van der Byl, Willem ;
Peters, Timothy J. ;
Martin, Ben P. ;
Martelotto, Luciano G. ;
Nuessing, Simone ;
Ramsbottom, Kelly M. ;
Torpy, James R. ;
Knight, Deborah ;
Reading, Sinead ;
Thia, Kevin ;
Miosge, Lisa A. ;
Howard, Debbie R. ;
Gloury, Renee ;
Gabriel, Sarah S. ;
Utzschneider, Daniel T. ;
Oliaro, Jane ;
Powell, Jonathan D. ;
Luciani, Fabio ;
Trapani, Joseph A. ;
Johnstone, Ricky W. ;
Kallies, Axel ;
Goodnow, Christopher C. ;
Parish, Ian A. .
NATURE COMMUNICATIONS, 2021, 12 (01)
[50]   A smart local moving algorithm for large-scale modularity-based community detection [J].
Waltman, Ludo ;
van Eck, Nees Jan .
EUROPEAN PHYSICAL JOURNAL B, 2013, 86 (11)